Literature DB >> 28008352

Low-dose quetiapine complements stimulant response in attention deficit hyperactivity disorder and more.

Ahmed Naguy1.   

Abstract

Entities:  

Year:  2016        PMID： 28008352      PMCID： PMC5167086          DOI： 10.1177/2045125316672545

Source DB:  PubMed          Journal:  Ther Adv Psychopharmacol        ISSN： 2045-1253


× No keyword cloud information.
  11 in total

1.  The dopamine dilemma: using stimulants and antipsychotics concurrently.

Authors:  Jason Yanofski
Journal:  Psychiatry (Edgmont)       Date:  2010-06

Review 2.  Advances and considerations in attention-deficit/hyperactivity disorder pharmacotherapy.

Authors:  Mohammad Mohammadi; Shahin Akhondzadeh
Journal:  Acta Med Iran       Date:  2011

Review 3.  The worldwide prevalence of ADHD: a systematic review and metaregression analysis.

Authors:  Guilherme Polanczyk; Maurício Silva de Lima; Bernardo Lessa Horta; Joseph Biederman; Luis Augusto Rohde
Journal:  Am J Psychiatry       Date:  2007-06       Impact factor: 18.112

Review 4.  Attention-deficit/hyperactivity disorder with inadequate response to stimulants: approaches to management.

Authors:  Ann C Childress; Floyd R Sallee
Journal:  CNS Drugs       Date:  2014-02       Impact factor: 5.749

5.  Managing ADHD and disruptive behaviour disorders with combination psychostimulant and antipsychotic treatment.

Authors:  Dean Elbe; Alasdair M Barr; William G Honer; Ric M Procyshyn
Journal:  J Psychiatry Neurosci       Date:  2014-05       Impact factor: 6.186

Review 6.  Use of quetiapine in children and adolescents.

Authors:  Gabriele Masi; Annarita Milone; Stefania Veltri; Raffaella Iuliano; Chiara Pfanner; Simone Pisano
Journal:  Paediatr Drugs       Date:  2015-04       Impact factor: 3.022

Review 7.  ADHD and comorbidity in childhood.

Authors:  Thomas J Spencer
Journal:  J Clin Psychiatry       Date:  2006       Impact factor: 4.384

Review 8.  Antipsychotic and psychostimulant drug combination therapy in attention deficit/hyperactivity and disruptive behavior disorders: a systematic review of efficacy and tolerability.

Authors:  David Linton; Alasdair M Barr; William G Honer; Ric M Procyshyn
Journal:  Curr Psychiatry Rep       Date:  2013-05       Impact factor: 5.285

Review 9.  Current pharmacotherapy of attention deficit hyperactivity disorder.

Authors:  D S Reddy
Journal:  Drugs Today (Barc)       Date:  2013-10       Impact factor: 2.245

Review 10.  Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II.

Authors:  Elizabeth Pappadopulos; James C Macintyre Ii; M Lynn Crismon; Robert L Findling; Richard P Malone; Albert Derivan; Nina Schooler; Lin Sikich; Laurence Greenhill; Sarah B Schur; Chip J Felton; Harvey Kranzler; David M Rube; Jeffrey Sverd; Molly Finnerty; Scott Ketner; Sonja E Siennick; Peter S Jensen
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2003-02       Impact factor: 8.829
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.